Marcia Angell, M.D.

Senior Lecturer on Social Medicine
  • 617/432-2570

Former editor-in-chief of the New England Journal of Medicine, Dr. Angell is widely recognized as a national leader in areas of health policy and medical ethics. In the Department of Global Health and Social Medicine, she is a key contributor to Division of Medical Ethics programs and planning. Her primary responsibility is to organize and moderate the Faculty Seminar Series, which attracts health care professionals from across the University and affiliated hospitals to monthly presentations and discussions. She also teaches in the Medical Ethics Fellowship. Beyond her teaching responsibilities, Dr. Angell invests significant time and energy in increasing public awareness of health issues, particularly health care reform and financial conflicts of interest in medical research, education, and practice.

  1. Angell M. Shattering the glass ceiling. April 1, 2014. JAMA internal medicine.

    Link to Abstract
  2. Angell M. Relationships with the drug industry: Keep at arm's length. February 3, 2009. BMJ (Clinical research ed.).

    Link to Abstract
  3. Angell M. Privatizing health care is not the answer: lessons from the United States. October 6, 2008. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

    Link to Abstract
  4. Angell M. Industry-sponsored clinical research: a broken system. September 3, 2008. JAMA : the journal of the American Medical Association.

    Link to Abstract
  5. Angell M. Academic medical centers and conflicts of interest. June 28, 2006. JAMA : the journal of the American Medical Association.

    Link to Abstract
  6. Angell M. Excess in the pharmaceutical industry. December 7, 2004. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

    Link to Abstract
  7. Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, Cho M, Coull BC, Davis D, Doolittle RF, Egilman D, Epstein SS, Greenberg M, Hooper K, Huff J, Joshi TK, Krimsky S, LaDou J, Levenstein C, Miles S, Needleman H, Pellegrino ED, Ravanesi B, Sass J, Schecter A, Schneiderman JS, Schubert D, Soffritti M, Suzuki D, Takaro TK, Temple NJ, Terracini B, Thompson A, Wallinga D, Wing S. Editorial policies on financial disclosure. October 1, 2003. Nature neuroscience.

    Link to Abstract
  8. Woolhandler S, Himmelstein DU, Angell M, Young QD. Proposal of the Physicians' Working Group for Single-Payer National Health Insurance. August 13, 2003. JAMA : the journal of the American Medical Association.

    Link to Abstract
  9. Relman AS, Angell M. America's other drug problem: how the drug industry distorts medicine and politics. December 16, 2002. New republic (New York, N.Y.).

    Link to Abstract
  10. Williams R, Schneiderman N, Relman A, Angell M. Resolved: psychosocial interventions can improve clinical outcomes in organic disease--rebuttals and closing arguments. July 1, 2002. Psychosomatic medicine.

    Link to Abstract
  11. Relman AS, Angell M. Resolved: psychosocial interventions can improve clinical outcomes in organic disease (con). July 1, 2002. Psychosomatic medicine.

    Link to Abstract
  12. Angell M. Medicine: the endangered patient-centered ethic. February 1, 1987. The Hastings Center report.

    Link to Abstract

Harvard Medical School
Department of Social Medicine
641 Huntington Ave
Boston MA 02115